April 24, 2025
Newsletter April 2025
- Caroline van der Meijden appointed as Interim Director iMTA
- Our Research: Betahistine and cinnarizine for the treatment of Meniere’s disease, vertigo and tinnitus in Switzerland.
- Our recent work for nice: Relugolix-estradiol-norethisterone for treating symptoms of enometriosis, Selpercatinib for advanced thyroid cancer, Ruxolitinib for treating acutue graft versus host disease refractory to corticosteroids and Efanesoctocog alfa for treating and preventing bleeding episodes in haemophilia.
- Our course: Cost-effectiveness modelling in practice
- and more.
Read our newsletter HERE